Novartis AG logo

Novartis AG

NVS · NYSE · Health Technology, Pharmaceuticals Major · Founded 1996

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Current Price
$161.10
Market Cap
$294B
Return Since Last Split
—
Last Split
Apr 9, 2019
Total Splits
2
Cumulative Multiple
2.232×

What If You Bought NVS Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$35,958
223 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth from that date to today.

Split DatePrice BeforeRatioSplit MultipleCumulative
Apr 9, 2019—279-for-2501.116×2.232×
May 11, 2000$32.262-for-12×2×

Novartis AG Market Cap Timeline

Validated annual market-cap history is available from 1998. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

Novartis AG's latest record in the split calendar is a 279-for-250 forward split effective 2019-04-09.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.